HOME › DRUGS › DAPRODUSTAT
ACTIVE SUBSTANCE / INN

DAPRODUSTAT

Brand name(s): Jesduvroq, JESDUVROQ
FDA LISTED
EMA LISTED
APPLICATION WITHDRAWN
DISCONTINUED
NDA216951
Renal Insufficiency, Chronic;Anemia
ACTIVE SUBSTANCE
Daprodustat
REGULATORS
FDA · EMA
SPONSORS / MAH
GLAXOSMITHKLINE, GlaxoSmithKline Trading Services Limited
TOTAL APPLICATIONS
2
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
JESDUVROQNDA216951GLAXOSMITHKLINEDiscontinued
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
JesduvroqGlaxoSmithKline Trading Services LimitedApplication withdrawnRenal Insufficiency, Chronic;Anemia

FULL INTELLIGENCE ON DAPRODUSTAT

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →